Prospective, early, intensified controll of central retinal thickness by optical coherence tomography to detect early recurrence of disease after treatment of neovascular Age-related macula degeneration (nAMD) by intravitreal injectio

Not Applicable

• Conditions: H35.3; Degeneration of macula and posterior pole

• Registration Number: DRKS00010061
• Lead Sponsor: Zentrum für AugenheilkundeUniklinik Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-04-04
• Study Completion: 2016-09-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

Patients with indications for treatment of exudative AMD at the Centre for Ophthalmology , which also carry out the follow-up for recurrence detection here

Willingness and consent to participate in the study

Exclusion Criteria

Physical or mental conditions which make the investigation for the patient appear unreasonable ( for example, severe dementia , severe immobility , limitation of movement in the cervical spine )

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measurement of central retinal thickness (CRT) with optical coherence tomography (OCT) in micrometers on day 7, 14 and 21 after intravitreal injection for neovascular AMD

Secondary Outcome Measures

Name	Time	Method
Analysis of OCT morphology in nAMD with CNV (choroidal neovascularisation) in the early phase after anti-VEGF injection<br>